已知肺栓塞的全关节置换术患者全外显子组测序:一项先导研究
该先导研究对来自三家学术机构的21例全关节置换术后发生肺栓塞的患者进行全外显子组测序,患者平均年龄64岁(范围46至81岁),其中女性15例(71.4%)。测序发现13例(61.9%)患者至少携带一个凝血相关基因突变,突变频率高于ClinVar数据库一般人群基线。作者认为这些结果提示全外显子组测序的基因突变在术后肺栓塞患者中高发,应作为初步数据支持进一步研究,以便关节置换外科医生术前进行风险分层。
要点
- 21例全关节置换术后肺栓塞患者中,13例(61.9%)检出至少一个凝血相关基因突变。
- 突变涉及凝血级联、血小板功能或血型相关的10个基因。
- 作者认为结果提示基因突变在术后肺栓塞患者中高发,应作为初步数据支持进一步研究。
核心结论
- 作者认为全外显子组测序的基因突变在全关节置换术后发生肺栓塞的患者中高度流行。
- 作者认为这些发现应作为初步数据,支持进一步研究全外显子组测序的潜在遗传风险因素,以便关节置换外科医生术前进行风险分层。
研究设计与样本
- 2017年6月至2021年8月,来自三家学术机构的21例有全关节置换术史且术后发生肺栓塞的患者入组接受全外显子组测序。
- 患者平均年龄64岁(范围46至81岁),女性15例(71.4%),肺栓塞平均发生时间1.7个月(范围0至8.8个月)。
- 5例患者报告既往血栓栓塞史,1例有因子V Leiden突变史。
- 从个体冷冻血样提取基因组DNA,片段化DNA转化为接头连接的全基因组文库,个体患者文库混合后测序,并通过美国国家生物技术信息中心文库ClinVar数据库与人群数据比较。
- ClinVar中一般人群凝血相关基因的突变等位基因频率范围为0.001%至1.52%。
主要发现
- 全外显子组测序在13例患者(61.9%)中检出所研究的30个凝血相关基因中至少一个突变。
- 检出凝血级联、血小板功能或血型相关的10个基因中至少一个突变。
- 凝血相关基因突变的发生率高于ClinVar数据库所识别人群基线。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to identify genetic mutations in exome sequences of patients who had a history of pulmonary embolism (PE) after total joint arthroplasty (TJA). METHODS: From June 2017 to August 2021, 21 patients who had a history of TJA and subsequent postoperative PE were enrolled in three academic institutions for whole-exome sequencing. Their average age was 64 years (range, 46 to 81), and 15 (71.4%) were women. The average time to PE was 1.7 months (range, zero to 8.8). There were five patients who reported a prior history of thromboembolism, and one had a history of Factor V Leiden mutation. Genomic DNA was extracted from individual frozen blood samples, and fragmented DNA was then converted to an adapter-ligated whole-genome library. Libraries from individual patients were pooled, underwent sequencing, and were compared to population-wide data through the National Center for Biotechnology Information Library, ClinVar database, which archives and aggregates information regarding the relationships between genomic variation and health conditions. Within ClinVar, the range of mutation allele frequency in genes with established roles in coagulation in the general population is reported to be 0.001 to 1.52%. RESULTS: Mutations in genes with established roles in coagulation occurred at higher rates compared to population baselines identified in the ClinVar database. In our cohort, whole-exome sequencing identified at least one mutation of the 30 genes investigated with established roles in coagulation in 13 patients (61.9%). At least one mutation in 10 genes related to the coagulation cascade, platelet function, or blood type was identified. CONCLUSIONS: Our results suggest that genetic mutations in exome sequences are highly prevalent among patients who experience postoperative PE after TJA. These findings should serve as preliminary data to support further investigation of potential genetic risk factors on whole-exome sequencing to allow for preoperative risk stratification by TJA surgeons.
引用
- Mayfield CK, Lechtholz-Zey EA, Ayad M, et al. Whole-Exome Sequencing of Total Joint Arthroplasty Patients Who Have Known Pulmonary Embolism: A Pilot Study. J Arthroplasty. 2025. PMID: 40499742. doi:10.1016/j.arth.2025.06.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。